Exhaled nitric oxide is not altered in patients with obstructive sleep apnea syndrome Source: Annual Congress 2007 - Airway regulation, provocation and monitoring II Year: 2007
Concentration of exhaled nitric oxide (FENO ) in patients with obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004
Effect of nasal CPAP on exhaled nitric oxide in patients with obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007
Nitric oxide in airways of patients with obstructive sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
Increased alveolar nitric oxide by trumpet model in patients with obstructive sleep apnoea Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012
Alveolar but not airway fractional exhaled nitric oxide concentration (FENO) is decreased in obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 467s Year: 2003
Oxydative stress in obstructive sleep apnea: Value of fractional exhaled nitric oxide measurement Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018
impact of continous positive airway pressure therapy on exhaled nitic oxide in obstructive sleep apnea syndrome Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019
Oral nitric oxide in obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Obstructive sleep apnoea, inspiratory flows and exhaled nitric oxide Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006
Nitric oxide and obstructive sleep apnea syndrome (OSAS): reflection of inflammation and oxidative stress Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Nitric oxide metabolites and erythrocyte deformability in a group of subjects with obstructive sleep apnea syndrome Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing Year: 2014
Exhaled nitric oxide in obstructive sleep apnea (OSA) patients: short and long term response to automatic positive airway pressure (APAP) therapy Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Interrelationships between oxidative stress and MMP-9 in subjects with severe obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
The influence of short-term therapy of continous positive airway pressure (CPAP) on exhaled nitric oxide concentration (FENO ) in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005
Factors influencing airway inflammation measured by exhaled NO levels in a population with obstructive sleep apnea syndrome (OSA) Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Overnight changes in exhaled carbon monoxide levels in obstructive sleep apnoea Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018
The role of inflammatory mediator in exhaled breath condensate of obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 331s Year: 2004
Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019
Decreased plasma levels of nitric oxide (NO) derivatives in obstructive sleep apnea (OSA): response to automatic positive airway pressure (APAP) therapy Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007